At 24 months, CHB-NAFLD patients tended towards lower rates of CVR compared to CHB-only patients with an odds ratio of 0.67 (0.41-1.09, p=0.10, I 2 =56%), but this result did not reach statistical significance.
← all excerpts
The co-existence of NAFLD and CHB is associated with suboptimal viral and biochemical response to CHB antiviral therapy: a systematic review and meta-analysis.
1
—
—